Showcasing Early Discovery of Biomarkers Against TREM2 for Alzheimer’s Disease

Time: 4:15 pm
day: Day One


• Detailing molecular investigations to identify TREM2 pathway-implicated biomarkers in pre-clinical models

• Assessing biomarker use for monitoring efficacy of anti-inflammatory therapies

• Translatable biomarker development efforts to predict and identify neuroinflammation progression in neurodegeneration